Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/7559
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-06-14T15:08:39Z-
dc.date.available2022-06-14T15:08:39Z-
dc.date.issued2018-12-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/7559-
dc.subjectControle de Medicamentos e Entorpecentespt_BR
dc.subjectDrug and Narcotic Controlpt_BR
dc.subjectControl de Medicamentos y Narcóticospt_BR
dc.titleRastreabilidade de medicamentos tem seu início em um piloto na Farmácia ambulatorial do HC Ipt_BR
dc.title.alternativeInforme INCA 378pt_BR
dc.TypeOtherpt_BR
Appears in Collections:INFORME INCA 378

Files in This Item:
File Description SizeFormat 
Informe-INCA-2018-378-10-Rastreabilidade-de-medicamentos.pdf212.44 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.